1111-210 The predictive value of QRS duration as a marker of ventricular dyssynchrony

Ghosh, Justin; Thackray, Simon; Desilva, Ramesh; Hurren, S.; Kaye, G.; Cleland, John G.F.

doi:10.1016/s0735-1097(04)90551-7

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…If CRT is to be deployed effectively it is important not to miss patients with a narrow QRS who may benefit [29] and those with a broad QRS who may not. Imaging techniques may be a more accurate way of identifying patients with dyssynchrony but require more skill in the generation and interpretation of the result [27–31]. Tissue Doppler mapping techniques appear a promising approach that may be simple to interpret, although it depends on movement in the longitudinal axis of the heart [30,31].…”

Section: New Information On Cardiac Resynchronisation Therapy (Crtmentioning

confidence: 99%

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Cleland

Ghosh

Freemantle

et al. 2004

European J of Heart Fail

Self Cite

206

101

View full text Add to dashboard Cite

This article continues a series of reports on recent research developments in the field of heart failure. Key presentations made at the American College of Cardiology meeting, held in New Orleans, Louisiana, USA in March 2004 are reported. These new data have been added to existing data in cumulative meta-analyses. The WATCH study randomised 1587 patients with heart failure and left ventricular systolic dysfunction to warfarin, aspirin or clopidogrel. The study showed no difference between the effects of these agents on mortality or myocardial infarction, but hospitalisations for heart failure were higher on aspirin (22.2%) compared to warfarin (16.1%). The SCD-HeFT study showed that ICD therapy reduced all-cause mortality at 5 years by 23% in patients with predominantly NYHA class II heart failure and left ventricular systolic dysfunction, but amiodarone was ineffective. The DINAMIT study showed that ICD therapy was not beneficial in patients with left ventricular dysfunction after a recent MI, even in those with risk factors for arrhythmic death. In CASINO, levosimendan improved survival compared with dobutamine or placebo in patients with decompensated heart failure. INSPIRE showed that SPECT imaging can be used to assess risk early after acute MI safely and accurately. Rimonabant was shown to be safe and effective in treating the combined cardiovascular risk factors of smoking and obesity. An overview of new developments in cardiac resynchronisation therapy (CRT) in heart failure is also reported.

show abstract

Section: New Information On Cardiac Resynchronisation Therapy (Crtmentioning

confidence: 99%

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Cleland

Ghosh

Freemantle

et al. 2004

European J of Heart Fail

Self Cite

206

101

View full text Add to dashboard Cite

show abstract

1111-210 The predictive value of QRS duration as a marker of ventricular dyssynchrony

Cited by 1 publication

References 0 publications

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

Contact Info

Product

Resources

About